Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FAWAD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,498
Award facts
- Contract value 100% obligated
- $11,498.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,498.30 to DMS Pharmaceutical Group Inc. for the supply of Xeljanz XR 11 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a specific pharmaceutical product fulfillment under DMS Pharmaceutical Group's larger contract vehicle with DLA. The order carries no set-aside designation and will be performed at the company's location in Conshohocken, Pennsylvania.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, holds a significant single-award Indefinite Delivery Contract with DLA under the SPE2DB program valued at $499,999,999 through November 2026. This IDC enables DLA to issue firm fixed-price delivery orders for pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The present delivery order for Xeljanz XR represents one of many pharmaceutical fulfillments issued under this master contract, demonstrating DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FAWAD?
SPE2DB25FAWAD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FAWAD worth?
The government has obligated $11,498 on SPE2DB25FAWAD.
Is contract SPE2DB25FAWAD an order under another contract?
Yes. SPE2DB25FAWAD is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWAD competed?
The extent of competition for SPE2DB25FAWAD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award